We are live on ! Find out more
AGN

Allergan Inc
AGN

Delisted

AGN was delisted on the 16th of March, 2015.

9 hedge funds and large institutions have $4.19M invested in Allergan Inc in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more capital invested

Capital invested by funds: $3.63M → $4.19M (+$565K)

13% more funds holding

Funds holding: 89 (+1)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change

AGN Hedge Fund Activity: Q4 2019 in Review

9 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Allergan Inc (AGN) for Q4 2019, worth a combined $4.19M — up 16% from $3.63M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new AGN positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.

The largest buyer was Sonora Investment Management, opening a new position worth an estimated $85K. The largest seller was Callahan Advisors, cutting an estimated $8.22K.

  • 9 institutional investors held Allergan Inc (AGN) as of Q4 2019, up from 8 in Q3 2019.
  • Funds reported $4.19M of Allergan Inc stock for Q4 2019, up 16% quarter-over-quarter.
  • 1 fund opened new Allergan Inc positions in Q4 2019 and 0 closed out, a net change of +1 holder.
  • The largest Allergan Inc buyer in Q4 2019 was Sonora Investment Management, an estimated $85K added.
  • The largest Allergan Inc seller in Q4 2019 was Callahan Advisors, an estimated $8.22K sold.

Based on aggregated 13F filings for Q4 2019.